ArticleKidney3602026
Association of Early Heart Failure Symptoms and Subsequent Heart Failure Hospitalizations and Mortality among Dialysis Patients.
Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
key pointsPatients treated with dialysis have a high burden of heart failure symptoms and functional limitations. Higher burden of heart failure symptoms are associated with higher rates of subsequent heart failure hospitalizations. Higher burden of symptoms are associated with higher risk of death.
backgroundDiagnosing heart failure (HF) in dialysis patients is challenging because of overlapping symptoms of volume overload. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a health status questionnaire measuring HF symptoms and functional limitations, with lower scores indicating greater burden.
methodsWe studied 625 Chronic Renal Insufficiency Cohort study participants who developed ESKD and had KCCQ scores post-ESKD diagnosis treated with hemodialysis or peritoneal dialysis. The primary outcomes were rates of HF hospitalization, 30-day HF readmission, and all-cause mortality. KCCQ was modeled dichotomously (<75 versus ≥75) and continuously (per five-point decrement). Poisson regression with robust standard errors was used to test the association of KCCQ score with each outcome.
resultsAmong 625 participants (mean age 59 years; 60% male; 87% on hemodialysis), median follow-up from KCCQ evaluation was 6.8 (interquartile range, 3.2-12.0) years. Those with KCCQ <75 had nearly twice the rate of HF hospitalizations (15.4 versus 8.4/100 person-years) compared with KCCQ ≥75. Each five-point decrement in KCCQ was associated with 9% higher adjusted relative risk (aRR) of HF hospitalization ( P = 0.0003), 7% higher aRR of 30-day HF readmission ( P = 0.03), and 6% higher aRR of all-cause mortality ( P < 0.001). Stratified by HF subtype, patients with HF with reduced ejection fraction and KCCQ <75 had 81% higher aRR of HF hospitalization versus those with KCCQ ≥75 ( P = 0.02). Decline in KCCQ by ≥5 from pre-ESKD to post-ESKD was associated with >40% increase in aRR of all-cause mortality ( P = 0.02).
conclusionsHigher HF symptom burden and functional limitations at dialysis initiation are independently associated with increased risk of HF hospitalization and all-cause mortality, suggesting that the KCCQ score may help predict outcomes early in the course of treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.